A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat.
Amantadine (100 mg/kg), apomorphine (2.5-10 mg/kg) and bromocriptine (10-50 mg/kg) all produced stereotyped behaviour in the rat. Apomorphine was rapid in onset and of short duration, amantadine was slower to reach a maximum and bromocriptine had a delayed onset of 50 min and a prolonged action. Amantadine and bromocriptine were antagonised by pimozide (1 mg/kg for 30 min) suggesting an action on dopamine receptors, and by D,L-alpha-methyl-p-tyrosine (150 mg/kg for 3 h) suggesting an indirect action. Amantadine, though not bromocriptine, antagonised apomorphine and amantadine also reversed the SBR due to bromocriptine. Pretreatment of rats with p-chlorophenylalanine (100 mg/kg twice daily for 2 days) had no effect on bromocriptine. The significance of these results is discussed with reference to the proposed mechanism of action of bromocriptine and to the use of multiple drug therapy in Parkinsonism.
D000547:Amantadine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D001519:Behavior; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior
D008781:Methyltyrosines; D010868:Pimozide; D000547:Amantadine; D001058:Apomorphine; D010134:Fenclonine